These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 12090057)
1. [Doxazosin, of modified liberation, in hemodialyzed patients]. Ocharán-Corcuera J; Iribar I; Saracho R; Martínez I; Montenegro J An Med Interna; 2002 Apr; 19(4):176-8. PubMed ID: 12090057 [TBL] [Abstract][Full Text] [Related]
2. Effect of doxazosin gastrointestinal therapeutic system as third-line antihypertensive therapy on blood pressure and lipids in the Anglo-Scandinavian Cardiac Outcomes Trial. Chapman N; Chang CL; Dahlöf B; Sever PS; Wedel H; Poulter NR; Circulation; 2008 Jul; 118(1):42-8. PubMed ID: 18559700 [TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up study to evaluate the efficacy and safety of the doxazosin gastrointestinal therapeutic system in patients with benign prostatic hyperplasia with or without concomitant hypertension. Chung BH; Hong SJ BJU Int; 2006 Jan; 97(1):90-5. PubMed ID: 16336335 [TBL] [Abstract][Full Text] [Related]
4. [Efficacy and tolerance of doxazosin in the treatment of isolated systolic hypertension in hypertensive patients over 60 years of age]. Calvo C; López E; Barrio E; Espejo J; Ruiz M; Vega A An Med Interna; 1995 Mar; 12(3):122-6. PubMed ID: 7795118 [TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism. Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914 [TBL] [Abstract][Full Text] [Related]
6. Doxazosin GITS versus standard doxazosin in mild to moderate hypertension. Calvo C; Gil-Extremera B; Gomez-Fernández P; Masramon X; Pueyo C; Armada B Int J Cardiol; 2005 May; 101(1):97-104. PubMed ID: 15860390 [TBL] [Abstract][Full Text] [Related]
7. Safety and effectiveness of replacing standard doxazosin with doxazosin in the gastrointestinal therapeutic system (GITS) formulation in elderly hypertensive patients. Jiménez-García R; Anegón M; Esteban J; Carrasco P; Apaolaza I; Gil A Int J Clin Pract; 2003 May; 57(4):267-72. PubMed ID: 12800456 [TBL] [Abstract][Full Text] [Related]
8. Clinical ease of using doxazosin in BPH patients with and without hypertension. Steers WD; Kirby RS Prostate Cancer Prostatic Dis; 2005; 8(2):152-7. PubMed ID: 15711605 [TBL] [Abstract][Full Text] [Related]
9. Doxazosin: safety and efficacy in the treatment of resistant arterial hypertension. Ceral J; Solar M Blood Press; 2009; 18(1-2):74-7. PubMed ID: 19353415 [TBL] [Abstract][Full Text] [Related]
10. Doxazosin in elderly patients with hypertension. Weinberger MH; Fawzy A Int J Clin Pract; 2000 Apr; 54(3):181-9. PubMed ID: 10829361 [TBL] [Abstract][Full Text] [Related]
11. Effect of doxazosin gastrointestinal therapeutic system on patients with uncontrolled hypertension: the ASOCIA Study. de Alvaro F; Hernández-Presa MA; J Cardiovasc Pharmacol; 2006 Feb; 47(2):271-6. PubMed ID: 16495766 [TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic free calcium mobilization in platelets, expression of P-selectin, phosphatidylserine, and microparticle formation, measured by whole blood flow cytometry, in hypertensive patients. Effect of doxazosin GITS. Labiós M; Martínez M; Gabriel F; Guiral V; Ruiz-Aja S; Aznar J Thromb Res; 2006; 117(4):403-9. PubMed ID: 16461073 [TBL] [Abstract][Full Text] [Related]
13. [Effects of monotherapy with an alpha1-adrenoblocker doxazosin and its combination with beta1-adrenoblocker atenolol on hemodynamics, reversible myocardial ischemia in postmyocardial infarction patients with arterial hypertension]. Tepliakov AT; Gavrilova NV; Garganeeva AA Klin Med (Mosk); 2003; 81(11):17-21. PubMed ID: 14689703 [TBL] [Abstract][Full Text] [Related]
14. The bedtime administration of doxazosin controls morning hypertension and albuminuria in patients with type-2 diabetes: evaluation using home-based blood pressure measurements. Kamoi K; Ikarashi T Clin Exp Hypertens; 2005 May; 27(4):369-76. PubMed ID: 15921073 [TBL] [Abstract][Full Text] [Related]
15. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug. Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208 [TBL] [Abstract][Full Text] [Related]
16. Add-on therapy with doxazosin in patients with hypertension influences arterial stiffness and albuterol-mediated arterial vasodilation. Wykretowicz A; Guzik P; Krauze T; Adamska K; Milewska A; Wysocki H Br J Clin Pharmacol; 2007 Dec; 64(6):792-5. PubMed ID: 17635498 [TBL] [Abstract][Full Text] [Related]
17. Effect of doxazosin gastrointestinal therapeutic system on platelet degranulation and platelet-leukocyte microaggregate formation induced by physiologic shear stress in hypertension. Labiós M; Martínez M; Gabriel F; Guiral V; Aznar J Thromb Res; 2006; 118(4):447-53. PubMed ID: 16242179 [TBL] [Abstract][Full Text] [Related]
18. ACE inhibitor-based, directly observed therapy for hypertension in hemodialysis patients. Zheng S; Nath V; Coyne DW Am J Nephrol; 2007; 27(5):522-9. PubMed ID: 17700014 [TBL] [Abstract][Full Text] [Related]
19. Doxazosin and hydrochlorothiazide equally affect arterial wall thickness in hypertensive males with hypercholesterolaemia (the DAPHNE study). Doxazosin Atherosclerosis Progression Study in Hypertensives in the Netherlands. Hoogerbrugge N; de Groot E; de Heide LH; de Ridder MA; Birkenhägeri JC; Stijnen T; Jansen H Neth J Med; 2002 Oct; 60(9):354-61. PubMed ID: 12572707 [TBL] [Abstract][Full Text] [Related]
20. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study. Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z; Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]